Patents
Patents for C07C 233 - Carboxylic acid amides (28,881)
04/2006
04/12/2006EP1643986A2 Phenylcarboxylate beta-secretase inhibitors for the treatment of alzheimer s disease
04/12/2006EP1343771B1 3-ox(adi)azolylpropanohydroxamic acids useful as procollagen c-proteinase inhibitors
04/12/2006EP1005356B1 Novel antibacterial agents
04/12/2006CN1759099A Substituted aniline derivatives
04/12/2006CN1759096A Method for the purification of dimethylacetamide (DMAc)
04/12/2006CN1759095A N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives
04/12/2006CN1759093A Azide free process for preparing 1,2-diamino compounds
04/12/2006CN1758925A Methods of radiofluorination of biologically active vectors
04/12/2006CN1250519C Amine derivative with K channel regulation function and its preparing process and application
04/12/2006CN1250518C Amine derivative for preventing ischemic and anoxia damage of nerve and its medical application
04/12/2006CN1250207C 4, 4-diaryl butadienes compound and use of ultraviolet-ray filtering agent
04/11/2006US7026522 Production of 2-amino-2-[2- (4-alkylphenyl) ethyl] propane-1, 3-diols
04/11/2006US7026514 Compounds used to treat alcoholism
04/11/2006US7026511 Synthesis of N-vinylformamide
04/11/2006US7026510 Inhibitors of the chemotactic activation induced by the fraction C5a of complement and from other chemotactic proteins (chemokines) that y activate a 7-transmembrane-domain receptor; psoriasis, rheumatoid arthritis, ulcerative colitis, acute respiratory distress syndrome, fibrosis; antiischemic agents
04/11/2006US7026501 Inhibitors of α4 mediated cell adhesion
04/11/2006US7026498 Coordination catalyst containing ligand
04/11/2006US7026419 Adhesives and sealants
04/11/2006CA2229470C Process for the purification of an intermediate in the preparation of iopamidol
04/11/2006CA2217030C Protease inhibiting succinic acid derivatives
04/11/2006CA2198383C Benzene compound and pharmaceutical use thereof
04/11/2006CA2155013C C2 taxane derivatives and pharmaceutical compositions containing them
04/06/2006WO2006026747A3 Diphenylethylene compounds and uses thereof
04/06/2006US20060074111 Chemical compounds
04/06/2006US20060074110 Multicyclic compounds which inhibit leukocyte adhesion mediated by VLA-4
04/05/2006EP1642886A2 Saturated and unsaturated N-Alkamides exhibiting taste and flavor enhancement effect in flavor compositions
04/05/2006EP1641759A2 Malonamide derivatives
04/05/2006EP1641748A2 N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer s disease
04/05/2006EP1641744A2 Crystalline form of b2 adrenergic receptor agonist
04/05/2006EP1641740A1 Method for producing an optically active nitro compound
04/05/2006EP1641559A1 A silver-catalyst composition, a process for preparing the catalyst composition and a use of the catalyst composition for the epoxidation of ethylene
04/05/2006EP1641465A2 Combinations of an aryl aniline beta-2 adrenergic receptor agonist and a corticosteroid
04/05/2006EP1453777B1 Functionalized higher diamondoids
04/05/2006EP0933993B1 Substituted cyclopentane compounds useful as neuraminidase inhibitors
04/05/2006EP0897747B1 Nitration or carboxylation catalysts
04/05/2006CN1754899A Process for the solid phase synthesis of aldehyde, ketone, oxime, amine, hydroxamic acid and alpha, beta-unsaturated carboxylic acid and aldehyde compounds
04/05/2006CN1754873A Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
04/05/2006CN1249210C Asymmetrical imide bleaching activators and compositions employing the same
04/05/2006CN1249020C Aromatic diamide derivatives, chemicals for agricultural or horticultural use and usage thereof
04/05/2006CN1249019C Naphthylsalicylanilides as antimicrobial and antiinflammatory agents
04/04/2006US7022879 Phase change ink formulations, colorant formulations, and methods of forming colorants
04/04/2006US7022870 Antidepressants; sexual disorders; anticancer agnets; hormone replacement therapy
04/04/2006CA2258764C Inhibitors of oleamide hydrolase
03/2006
03/30/2006WO2006034277A1 Bicyclic compounds which inhibit beta-secretase activity and methods of use thereof
03/30/2006WO2006033000A2 N-ethyl hydroxyethylamine useful in treating cns conditions
03/30/2006WO2006032999A1 N-methyl hydroxyethylamine useful in treating cns conditions
03/30/2006WO2006032893A2 Trityl derivatives for enhancing mass spectrometry
03/30/2006US20060069257 Use of specific bidentate ligands, e.g., 2-dicyclohexylphosphino-2'-dimethylamino-biphenyl, in transition metal-catalyzed carbon-heteroatom and carbon-carbon bond-forming reactions including amination and arylation and with aryl halide reactants and amine, boronic acid, borane or ketone reactants
03/30/2006CA2581023A1 N-methyl hydroxyethylamine useful in treating cns conditions
03/30/2006CA2580775A1 N-ethyl hydroxyethylamine useful in treating cns conditions
03/30/2006CA2580238A1 Bicyclic compounds which inhibit beta-secretase activity and methods of use thereof
03/29/2006EP1640359A2 Anticonvulsant and central nervous system-active bis(fluorophenyl)alkylamides
03/29/2006CN1247529C Process for preparing N-aroyl-L-glutaminic acid
03/29/2006CN1247528C Novel tricyclic compounds, preparation method and pharmaceutical compositions containing same
03/29/2006CN1247526C Diaminodicarboxylic acid and its intermediate
03/29/2006CN1247511C Tropolone derivative
03/28/2006US7019094 Intermediate products, methods for their preparation and use thereof
03/28/2006US7019020 2-benzoxazolyl benzene derivatives and their use as UV screening agents
03/28/2006US7018850 Luminescent lanthanide metal chelate for use as tool in diagnostic analysis
03/28/2006US7018610 Poly-L-R-Y, where poly represents a polymer( such as polystyrene homo or copolymer) R= aryl or heteroaryl, L= R3-Sn-R3 (R3= alkyl, alenyl or alkynyl), Y= hydrogen, alkyl, alkoxy, carbonyl, formyl, amido, amino, carobxyamido etc.
03/28/2006CA2395186C Procollagen c-proteinase inhibitors
03/28/2006CA2386793C New selective retinoid agonists
03/28/2006CA2244862C Substituted amide derivatives
03/28/2006CA2153805C C10 taxane derivatives and pharmaceutical compositions
03/23/2006WO2006030892A1 Process for production of heterocyclic compounds
03/23/2006WO2006029799A1 Iodine-phenyl-substituted cyclic cetoenols
03/23/2006US20060063843 Compounds for the treatment of inflammatory disorders
03/23/2006US20060063769 Preventives/remedies for urinary disturbance
03/23/2006US20060063759 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease
03/23/2006US20060062751 Novel surfactants and use thereof
03/23/2006US20060062726 with iodophenyl group (radioisotope), as a membrane component of liposomes, which enables lesion-selective contrast X-ray radiography of a vascular disease; metabolized in the liver, not accumulated in living bodies
03/23/2006DE10297824T5 Verfahren zum Einsatz von Wasserstoff zur reduktiven Acylierung von Nitro-, Azido- und Cyanarenen A method of using hydrogen for the reductive acylation of nitro, azido and cyano arenes
03/23/2006CA2580328A1 Iodine-phenyl-substituted cyclic ketoenols
03/23/2006CA2580131A1 Substituted aniline derivatives
03/22/2006EP1636191A2 Benzazepine derivatives useful for the treatment of 5ht2c receptor associated diseases
03/22/2006EP1636168A1 Method for continuously producing alkylamino(meth)acrylamides
03/22/2006CN1751020A Process for the preparation of N-substituted formamides
03/22/2006CN1751018A 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases
03/22/2006CN1750839A Administration of capsaicinoids
03/22/2006CN1749238A Saturated and unsaturated N-alkamides exhibiting taste and flavor enhancement effect in flavor compositions
03/22/2006CN1246300C Resorcinol derivatives
03/22/2006CN1246296C Process for preparing 2-ethyl-N-(ethoxy methyl)-alpha-chloroacetanilide
03/22/2006CN1246287C Binaphthol derivative and method for producing same
03/22/2006CN1245936C Detergent composition containing new glycine derivative and its use
03/21/2006US7015342 Enantiomerically enriched bidentate organophosphorus ferrocenyl ligands which are particularly useful for enantioselective hydrogenation
03/21/2006US7015200 Carbohydrates conjugated to optionally protected 4-hydroxybutyric acid; enhance the uptake of the drug and allows effective drug delivery to treat GHB-treatable disorders such as sleep disorders or drug withdrawal
03/21/2006CA2245647C Novel bridged cyclic amino acids as pharmaceutical agents
03/21/2006CA2147854C Taxanes having an alkyl substituted side-chain and pharmaceutical compositions containing them
03/16/2006WO2006029135A1 Improved process for the synthesis of indanylamine or aminotetralin derivatives and novel intermediates
03/16/2006WO2006027252A1 Sigma receptor ligands
03/16/2006WO2006026875A1 Anti-bacterial compounds
03/16/2006US20060058396 Amide compounds for the potentiation of cholinergic activity
03/16/2006US20060058298 Inhibitors of histone deacetylase
03/16/2006US20060057194 introducing a biologically active agent into a cell of a plant or animal comprising: contacting said cell with lipid vesicles comprising amino acid amide lipids in vivo or in vitro; gene therapy
03/16/2006DE102004037445A1 New indolizine and azaindolizine carboxamide derivatives, useful for treating e.g. schizophrenia and urinary incontinence, are ligands for serotinergic receptors
03/16/2006DE102004035978A1 New aminoadamantane derivatives useful for treating e.g. viral diseases, Parkinson's disease, Huntington's chorea, Alzheimer's disease, autism, tinnitus, Tourette syndrome, hypertension, sleep disorders and psychosis
03/16/2006CA2591321A1 Phenylaminopyrimidine derivatives as inhibitors of bcr-abl kinase
03/16/2006CA2577610A1 Sigma receptor ligands
03/15/2006EP1633762A1 Ligands
03/15/2006EP1633721A1 Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives